Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies.

Saved in:
Bibliographic Details
Title: Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies.
Authors: Greenwood, Christopher J., Foulds, James, McKetin, Rebecca, Aarsman, Stephanie R., Hutchinson, Delyse, Kerr, Jessica, Heerde, Jessica A., Toumbourou, John W., Boden, Joseph M., Slade, Tim, Bonomo, Yvonne, Letcher, Primrose, Olsson, Craig A.
Source: Addiction. Aug2025, Vol. 120 Issue 8, p1623-1633. 11p.
Subjects: Mental illness risk factors, Risk assessment, Research funding, Scientific observation, Sex distribution, Amphetamines, Descriptive statistics, Longitudinal method, Odds ratio, Research, Confidence intervals, Drugs of abuse, Drug utilization, Time, Adolescence, Adults
Geographic Terms: New Zealand, Australia
Abstract: Background and aims: The use of amphetamines (including amphetamine and methamphetamine) has been consistently associated with mental health difficulties; however, the direction of potential causal relationships has not yet been established. This study aimed to assess the direction relationships between illicit amphetamine use and mental health difficulties across adolescence and young adulthood. Design: Observational study of four population‐level cohorts participating in the Monitoring Illicit Substance Use (MISUse) Consortium. Setting: Australia and New Zealand. Participants: A total of 7527 participants (51% female) were used: Christchurch Health and Development Study (n = 1056), Australian Temperament Project (n = 1644), Victorian Adolescent Health Cohort Study (n = 1943) and International Youth Development Study (n = 2884). Measurements Assessments were used to derive binary indicators of amphetamine use (≥monthly) and mental health difficulties during both adolescence (age 10–17 years) and young adulthood (age 18–30 years). Findings Associations were estimated as Risk Ratios (RRs) with 95% confidence internals (CIs) using G‐computation procedures, while accounting for 15 potential confounding factors and interactions between exposure and both study cohort and participant sex. The risk of mental health difficulties in young adulthood was 21% greater (RR = 1.21, 95% CI = 1.04, 1.41) for those who reported monthly or more frequent amphetamine use in adolescence. The risk of monthly or higher amphetamine use in young adulthood was 19% greater (RR = 1.19, 95% CI = 0.99, 1.45) in those who reported mental health difficulties in adolescence. There was also some evidence to suggest that in males the strongest association was from amphetamine use to mental health difficulties (RR = 1.24, 95% CI = 0.95, 1.60), while in females the strongest association was from mental health difficulties to amphetamine use (RR = 1.33, 95% CI = 0.99, 1.78). Conclusions: There appears to be a bidirectional association between monthly or more frequent amphetamine use and mental health difficulties from adolescence to young adulthood. [ABSTRACT FROM AUTHOR]
Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Description
Abstract:Background and aims: The use of amphetamines (including amphetamine and methamphetamine) has been consistently associated with mental health difficulties; however, the direction of potential causal relationships has not yet been established. This study aimed to assess the direction relationships between illicit amphetamine use and mental health difficulties across adolescence and young adulthood. Design: Observational study of four population‐level cohorts participating in the Monitoring Illicit Substance Use (MISUse) Consortium. Setting: Australia and New Zealand. Participants: A total of 7527 participants (51% female) were used: Christchurch Health and Development Study (n = 1056), Australian Temperament Project (n = 1644), Victorian Adolescent Health Cohort Study (n = 1943) and International Youth Development Study (n = 2884). Measurements Assessments were used to derive binary indicators of amphetamine use (≥monthly) and mental health difficulties during both adolescence (age 10–17 years) and young adulthood (age 18–30 years). Findings Associations were estimated as Risk Ratios (RRs) with 95% confidence internals (CIs) using G‐computation procedures, while accounting for 15 potential confounding factors and interactions between exposure and both study cohort and participant sex. The risk of mental health difficulties in young adulthood was 21% greater (RR = 1.21, 95% CI = 1.04, 1.41) for those who reported monthly or more frequent amphetamine use in adolescence. The risk of monthly or higher amphetamine use in young adulthood was 19% greater (RR = 1.19, 95% CI = 0.99, 1.45) in those who reported mental health difficulties in adolescence. There was also some evidence to suggest that in males the strongest association was from amphetamine use to mental health difficulties (RR = 1.24, 95% CI = 0.95, 1.60), while in females the strongest association was from mental health difficulties to amphetamine use (RR = 1.33, 95% CI = 0.99, 1.78). Conclusions: There appears to be a bidirectional association between monthly or more frequent amphetamine use and mental health difficulties from adolescence to young adulthood. [ABSTRACT FROM AUTHOR]
ISSN:09652140
DOI:10.1111/add.70033